Skip to main content
Online First
Original Research, Clinical Trials, Drug–Drug Interaction
Pharmacist-Led Management of Concomitant Medications in Oncology Trials: A Retrospective Analysis of Screening and Enrollment Outcomes
A. Cameron Hill, PharmD, PhD; Camryn Froerer, PharmD, MS, BCSCP, BCPS; Benjamin Maughan, MD, PharmD
Read More
Online First
Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols, Supportive Care, Breast Cancer
Impact of Pharmacist-Driven Oral Chemotherapy Treatment Plan Implementation on Monitoring and Supportive Care Interventions During CDK4/6 Inhibitor Therapy for Patients With Breast Cancer
Morgan Felitte, PharmD; Hannah Kisla, PharmD, BCOP; Elizabeth Brady, PharmD, CSP; Darlene Tat, PharmD, MPH; Jessica Mills, PharmD; Jennifer McDonald, PharmD, BCPS
Read More
Online First
Practical Issues in Pharmacy Management, Clinical Trials, Cost of Care, Disparities in Oncology Care, Oncology Pharmacy Programs/Protocols
Review of the Regulatory Framework for Interstate Shipping of Investigational New Drugs
Donaciano Dominguez, PharmD, MBA; Jennifer Murphy, PharmD, BCOP; Matthew Serna, PharmD, BCPS; Tala Ataya, PharmD, MBA
Read More
Online First
Original Research, Adverse Events, Biosimilars
Arthralgia Rates and Treatment Among Patients Receiving Bevacizumab-awwb Versus Bevacizumab
Rachel Schneider, PharmD; Justin Grahl, PharmD; Susan Duyar-Ayerdi, MD, MA; Ruta Brazauskas, PhD; Bethany Canales, MPH; Erin McGurty, PharmD, BCOP
Read More
Online First
Original Research, Methotrexate, Case Reports
Glucarpi-CAP: A Retrospective Case Series of 1000-Unit Glucarpidase Dosing for Methotrexate Rescue
Sydney Ertz, PharmD; Joseph Bubalo, PharmD, BCOP, FHOPA
Read More
Online First
Original Research, Bispecific Antibodies, Multiple Myeloma
Expanding Bispecific T-Cell Engager Therapy for Multiple Myeloma to Community Settings: A Single-Institution Experience
Rahim Jiwani, MD; Samantha Maples, PharmD; Srinishant Rajarajan, MD; Kalaivani Babu, MD; Santhosh Sadashiv, MD; Prerna Mewawalla, MD
Read More
Online First
Original Research, Immunotherapy, Chemotherapy, Breast Cancer
Characterization of A Dose-Dense Doxorubicin and Cyclophosphamide Regimen for Triple-Negative Breast Cancer Within the KEYNOTE-522 Trial
Samantha Hodges, PharmD; Katelyn Patterson, PharmD; Vera Ljucovic, PharmD
Read More
Online First
Original Research, Adverse Events, Disparities in Oncology Care, Dose Escalation/Reduction, Immunotherapy, Multiple Myeloma
Characterizing Lenalidomide Dose Modifications Among Black and Non-Black Patients Receiving Induction Therapy for Newly Diagnosed Multiple Myeloma
Laura Fan Sun, PharmD, BCOP; Natalie Brumwell, PharmD; Kevin Hall, PharmD; Kristina Murphy, PharmD; Jeffrey Switchenko, PhD; Yichun Cao, MPH, et al.
Read More
Online First
Original Research, Lung Cancer, Immunotherapy, Adverse Events
Outcomes of Early Versus Delayed Initiation of Immunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
Matthew Warrick, PharmD, BCPS, BCOP; Rebecca Worden, PharmD, BCOP; Carly Kesler, PharmD, BCOP; Katie Murto, PharmD, BCOP; Amanda Edwards, PharmD, BCOP, CPP
Read More
Clinical Trials
Quality Improvement Strategies to Optimize Outpatient Step-Up Dosing for Elranatamab in Relapsed/Refractory Multiple Myeloma
Read More
Page 1 of 197
Results 1 - 10 of 1963